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Abstract
Many studies have documented barriers to colorectal cancer screenings. However, there is lack of 
comprehensive information on the time and costs borne by low-income patients and the persons 
accompanying the patient (caregiver) for colonoscopies in the United States. We surveyed patients 
in three health clinics in Philadelphia retrospectively who had undergone free colonoscopies in the 
previous 18-month period. Participants were asked questions about time and out-of-pockets 
expenses for themselves and their caregivers. Even when colonoscopies were free to the patient 
through Colorectal Cancer Control Program funded by the Centers for Disease Control and 
Prevention, the patient and caregivers still incurred costs in relation to preparing for, undergoing, 
and recovering from a colonoscopy. These costs can be substantial and may account for some of 
the low colorectal cancer screening rates especially among the low-income populations. Patients’ 
and caregivers’ costs need to be considered when designing and implementing colorectal cancer 
control programs.
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1. Introduction
Colorectal cancer (CRC) screening has been shown effective in reducing mortality from 
CRC (Zauber et al., 2008). The U.S. Preventive Services Task Force recommends CRC 
screening for average-risk adults aged 50–75 years using high-sensitivity fecal based test 
annually, sigmoidoscopies every 5 years with fecal-based testing every 3 years, or a 
colonoscopy once every 10 years (U.S Preventive Services Task Force, 2008). Yet the take-
up rate for any CRC screening remains low: less than 60% of men and women aged 50 and 
older are up-to-date with CRC screening (Sabatino, White, Thompson, & Klabunde, 2015). 
Among uninsured, fewer than 1 in 4 received the recommended screening for CRC 
(Sabatino et al., 2015). In an effort to increase CRC screening rates, the Centers for Disease 
Control and Prevention (CDC) established the Colorectal Cancer Control Program (CRCCP) 
in 2009. The CRCCP funded 29 grantees, both states and tribal organizations, for a period of 
6 years to support screening provision and promotion activities.
Many studies have documented barriers to cancer screenings in general and CRC screenings 
in particular. The barriers include low levels of education, language or communication 
challenges, low socioeconomic status, and lack of insurance coverage (Gimeno Garcia, 
2012; Heitman, Au, Manns, McGregor, & Hilsden, 2008; Subramanian, Klosterman, 
Amonkar, & Hunt, 2004). Cost has also been cited as a barrier (Jones, Devers, Kuzel, & 
Woolf, 2010; Klabunde et al., 2005). A report conducted by the National Institutes of 
Health’s Center to Reduce Cancer Health Disparities detailed three main cost categories: 
direct, indirect, and intangible costs. Direct medical costs are those related to the provision 
of clinical services, such as facilities and clinician fees, and cost of medical supplies 
including bowel prep products. Direct nonmedical costs include all costs not directly related 
to medical services such as transportation and child care costs. Indirect costs are also 
nonmedical costs and relate to cost of time lost from work (lost productivity cost) by the 
patient and caregivers as a result of their commitment to the clinical procedure. Intangible 
costs include costs associated with adverse effects from the clinical procedure on the quality 
of life (Center to Reduce Cancer Health Disparities (U.S.), 2007).
Few studies had examined the nonmedical costs (which includes direct nonmedical cost and 
indirect cost) of screening for CRC (Frew, Wolstenholme, Atkin, & Whynes, 1999; Heitman 
et al., 2008; Henry, Ness, Stiles, Shintani, & Dittus, 2007; Jonas, Russell, Sandler, Chou, & 
Pignone, 2007; Yabroff, Borowski, & Lipscomb, 2013). In a recent review, Yabroff and 
colleagues found that of 65 international studies published in 2000–2010, only 18 addressed 
costs for patient or caregiver time, travel, or lost productivity (Yabroff et al., 2013). These 
studies did not specifically focus on CRC screening, and they were mostly related to cancer 
care. There is no study to date that provides a comprehensive assessment of the cost to low-
income patients and those who accompany them for colonoscopy screening (caregivers) in 
the United States. These costs can be an important barrier for undergoing colonoscopy 
screening.
In this study we examine the costs borne by patients who underwent CRC screening and 
their caregivers at three community health centers in innercity Philadelphia, Pennsylvania. 
These clinics all participated in the CRCCP program in Pennsylvania and offered free 
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colonoscopy screening. This article provides an important contribution to the literature as it 
evaluates a potentially significant barrier to CRC screening among the disadvantaged low-
income population who are either uninsured or underinsured.
2. Methods
2.1. Questionnaire development
A questionnaire was developed and pretested that captured patient sociodemographic 
characteristics as well as time requirements and expenses incurred through the CRC 
screening process. In developing the questionnaire, we reviewed existing surveys and the 
published literature in order to use standardized questions where possible. Questions 
included time spent traveling, time spent waiting at the physician office, and time spent 
undergoing procedures. The questionnaire also collected details on the travel expenses for 
precolonoscopy visits, the colonoscopy procedure, and postcolonoscopy visits; bowel prep 
product and childcare expenses. Patients were also asked about how they traveled to the 
visits (e.g., private or public transportation) and whether they had someone to accompany 
them. Questions about the caregiver work status and position were asked to determine their 
costs incurred in assisting the patient. In this manuscript, “caregivers” refer to spouses, 
family members, and friends who accompanied the respondent to any colonoscopy 
appointments. Although colonoscopies were provided free through the CDC’s CRCCP to all 
patients; in some instances patients had to pay a proportion of the cost for bowel prep 
products. This would constitute direct medical cost and was captured when relevant.
Once the questionnaire was drafted, it was pretested to finalize wording of the questions and 
order of presentation. This study was approved by RTI International’s institutional review 
board and the Office of Management and Budget (OMB Control No. 0920-0963).
2.2. Data collection approach
One of the grantees of the CDC’s CRCCP was Pennsylvania, which funded clinics to 
provide colonoscopies at no cost to patients. The project team partnered with three funded 
community health centers in Philadelphia to conduct the study. We used a convenience 
sample of average risk individuals 50–74 years who has received CRCCP funded 
colonoscopy screening within an 18 month period (June 2012 to November 2013). Our goal 
was to complete 150 questionnaires to ensure that adequate sample was available for this 
exploratory analysis. Medical assistants reviewed patient charts and clinical records to 
identify patients who underwent CRCCP funded screening colonoscopies. The medical 
assistants then contacted the selected individuals in person (if they had an upcoming 
appointment at the center) or via telephone to explain the study and ask whether they would 
participate. After obtaining patient consent, the medical assistants scheduled an in person 
visit to complete the questionnaire. All patients who were approached, agreed to participate 
and there were no refusals. Patients received a $20 gift card as incentive. All questionnaires 
were administered in English and data collection occurred during November–December 
2013. A total of 150 questionnaires were administered in the three sites and deidentified data 
was compiled for analysis.
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2.3. Data analysis
Demographics and work status information were summarized for patients and caregivers. 
We categorized the time and cost into four activity groups: attend a precolonoscopy office 
visit, prepare for a visit, attend a colonoscopy visit, and attend a postcolonoscopy office 
visit. The amount of time spent for each visit was assumed to be the same for the patient and 
the caregiver (if the patient was accompanied).
We report the actual time and cost estimates in 2013 U.S. dollars for persons who incurred 
them, and the mean across all questionnaire respondents. To calculate the cost of lost time 
attending colonoscopy-related visits (opportunity cost), we used wage information ($11.68/h 
for respondents and $14.97/h for the caregivers) from the Bureau of Labor Statistics and 
took a weighted average based on occupation reported by those working. This ensures that 
the time of all individuals (those employed and those not in formal employment) is 
accounted for (Bureau of Labor Statistics, 2015). Also, if respondents did not report costs to 
travel to doctors’ offices, we assigned mileage costs of 23 cents per mile, based on Internal 
Revenue Service mileage allowance for medical purposes, and estimated a distance traveled 
of 10 miles each way. We learned that clients generally lived near the health centers, and we 
assumed that caregivers traveled together with the patients.
We do not separately report results based on data for less than 10 respondents, but we do 
include the information in aggregate results. For example, we do not report time missed for 
post-colonoscopy visits because few respondents who attended one missed work. However, 
we do include this time in the total time. We follow the same logic for data reported on 
costs. So few respondents reported requiring child care that we excluded them from the total 
costs.
3. Results
Patients who received free colonoscopies are described in Table 1. Three-quarters were 
women, and on average, they were 58.9 years old (range = 52–81). Most were African 
Americans (69.3%) and fluent in English (72.7%). Seventy-three percent of respondents had 
at least a high school diploma or the equivalent. Thirty-eight percent of respondents were 
employed either full- or part-time, and more than half (56.1%) were employed in the 
services industry (e.g., home health aide, firefighter, cook, maid, waitress, gardener/
landscaper). Only 16.0% had health insurance (private, Medicare, or Medicaid).
Respondents were asked about the people who accompanied them to the various 
colonoscopy appointments. All respondents had someone accompany them to attend at least 
one appointment. Most often (72.0%) this person was a family member or spouse. Among 
caregivers, 29.3% were employed full-time and 14.7% were employed part-time. Many of 
those who were employed (36.8%) were in the services industry.
Not all employed patients missed work for various parts of the colonoscopy process, likely 
because they were able to schedule the colonoscopy to fit their work obligations. Of 
employed respondents, 43.9% had to miss work to attend a precolonoscopy visit. Nearly 
one-quarter (22.8%) had to miss work to prepare for the colonoscopy, and slightly more than 
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half (50.9%) had to miss work for the colonoscopy itself. On average, employed respondents 
who missed work missed 6.1–8.0 h for each of the various colonoscopy appointments. 
Employed respondents missed 6.1 h of work for a precolonoscopy visit and 6.9 h preparing 
for and 7.4 h attending the colonoscopy.
Table 2 displays the time needed and estimated cost of this lost time for patients undergoing 
colonoscopies and caregivers. Patients spent approximately 1.2 h at a precolonoscopy visit 
and 0.9 h traveling to it, which resulted in $24.95 in lost time. Thirty-seven percent of 
patients had someone accompany them to the precolonoscopy visit, equaling $11.73 in lost 
time across all caregivers. To prepare for a colonoscopy, patients spent 16.9 h, including 
reading the bowel preparation instructions. This equaled $196.54 in lost time. Patients spent 
0.8 h traveling to and from the endoscopy center and 3.7 h having the colonoscopy resulting 
in a mean patient value of lost time of $51.97. Patients took 5.1 h to recover from the 
colonoscopy, translating into $59.80 in lost time. Only 13.3% of respondents reported 
having a postcolonoscopy visit. Across all respondents, patients spent 0.1 h in travel and 0.1 
h at the visit, and this translated into $2.68 in lost time. In total, patients needed 28.8 h to 
undergo the colonoscopy screening, resulting in an indirect average cost of $335.95, while it 
cost the caregiver $79.03.
Fig. 1 compares how respondents traveled to the precolonoscopy and the colonoscopy visits. 
Most respondents traveled to the precolonoscopy and colonoscopy visits by car (69% and 
89%, respectively). A small percentage of respondents paid to park at the doctor’s office 
(9.3% and 10. 7% for the precolonoscopy and colonoscopy visit, respectively). Three times 
as many respondents took public transportation or walked to the precolonoscopy 
appointment compared to the colonoscopy visit (31.3 versus 10.3%).
Table 3 shows travel and other costs for all colonoscopy visits. Across all patients, the travel 
costs were $13.10. The cost for traveling to the precolonoscopy visit was $5.54 and the 
travel cost to attend the colonoscopy was $6.75. Few attended a postcolonoscopy visit and 
the cost to travel to it was $0.81 when averaged across all patients. The average cost of the 
bowel preparation product was $4.36.
4. Discussion
In this study, based on retrospective self-reports, patients spent, on average, 23.7 h preparing 
for, traveling for and having a colonoscopy, and an additional 5.1 h, on average, recovering 
from the colonoscopy. This translated into a total cost of $335.95 for the patient in lost time 
and $79.03 for the caregiver. In addition, an estimated $17.46 was incurred in travel and 
other costs. Even when colonoscopy is provided free of charge to the patient, additional 
costs may be incurred which could be a significant barrier for low income individuals to 
receive CRC screening.
A few international studies have estimated the non-medical costs of screening colonoscopies 
but these estimates are not directly comparable to the present study that collected data on a 
low-income patients in the United States. Using patient questionnaires to collect nonmedical 
costs of both fecal occult blood test (FOBTs) and colonoscopies, researchers in Canada 
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found that the costs for both patients and caregivers averaged Can$308 (2006 U.S. $271) for 
colonoscopy and Can$36 (2006 U.S. $32) for FOBTs (Heitman et al., 2008). Examining the 
indirect cost of flexible sigmoidoscopies through the use of patient surveys in Great Britain, 
researchers found that indirect costs totaled approximately £23 (1999 U.S. $14.20) (Frew et 
al., 1999). A study that was performed in the United States did not report costs but estimated 
that the time required to complete the screening colonoscopy process as approximately 21 h, 
(Jonas et al., 2007) which is similar to the time reported in this study.
Overall, the total cost of undergoing a “free” colonoscopy screening is substantial for a low-
income patient, especially when the average hourly wage estimate used in this analysis for 
the patient was $11.68. This relatively high cost could explain the reason for the lower levels 
of compliance with screening recommendations among people with low education and 
generally low socioeconomic status (Centers for Disease Control and Prevention, 2013). 
Further, many service workers lack paid sick time, which may further impact the use of 
endoscopy tests (Peipins, Soman, Berkowitz, & White, 2012). The largest time cost was 
related to bowel preparation and undergoing the colonoscopy procedure; therefore, 
potentially, noninvasive fecal-based tests could result in lower burden in terms of time lost. 
Fecal tests, though, require much more frequent screening than colonoscopy and, therefore, 
may not effectively save much money over the long term. The need to repeat screening tests 
at regular intervals is also an important issue: if the need for multiple repeated screens is not 
met, especially for annual fecal tests, then there is a substantial reduction in the effectiveness 
of the test (Subramanian, Bobashev, & Morris, 2009; Subramanian, Bobashev, & Morris, 
2010). In addition, colonoscopy may be an appropriate surveillance test for high-risk 
individuals (those with a family history of CRC or other risk factors) (U.S. Preventive 
Services Task Force, 2015). Colonoscopy is also required for diagnostic follow-up testing 
when fecal-based tests are positive; therefore, understanding approaches to improve 
completion of the screening process with colonoscopies is an important aspect of any CRC 
initiative that relies on fecal tests.
The role of financial incentives to increase patient compliance with colonoscopy screening 
recommendations is an understudied area of research. Pignone et al. (2014), using a discrete 
choice experiment, found that participants undergoing CRC screening preferred rewards or 
small copayments, compared to large copayments. The most recent review published by the 
Guide to Community Preventive Services found insufficient evidence to recommend patient 
incentives (Sabatino et al., 2012). Systematic evaluation of the role of incentives in screening 
colonoscopy use among the low-income population is needed. In addition, comparative 
evaluation of the role of fecal-based tests compared with that of colonoscopies is also 
essential to assess each screening test’s ability to address the low screening rates among the 
low-income, underinsured, and uninsured populations.
The study has several limitations. First, the retrospective nature of the study could have 
resulted in recall bias related to the time allotted to specific screening procedures. Second, 
the estimates are based on a nonrandom sample of patients within one city, so these results 
may not be generalizable to other populations. In addition, we did not include a comparison 
group to assess differences in time and cost of undergoing colonoscopy. Third, these cost 
estimates are likely to be a conservative estimate of the overall cost incurred. For example, 
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costs for bowel preparation were low because we learned that a local store sold the product 
inexpensively and the health centers were able to provide free kits to some patients. Despite 
these limitations, the detailed breakout of the costs presented in this study offers program 
planners and policy makers a good approximation of the costs involved. This estimate can be 
tailored based on unique situations that may be present in the implementation of other 
colonoscopy screening programs.
5. Conclusions and lessons learned
The findings from this study offer insights into the economic barriers faced by low-income 
individuals when undergoing colonoscopy screening, even when the procedure itself is 
offered at no charge. Additional studies are required to understand the role of financial 
incentives and the most effective use of these incentives. The decision to undergo 
colonoscopy screening can be influenced by multiple interlinked factors, so financial 
incentives should be evaluated alongside other potential barriers. Financial incentives should 
be included in future assessments of health promotion interventions, as colonoscopy 
screening requires a substantial time commitment and the cost of lost time is significant, 
especially for the low-income population.
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Fig. 1. 
How Respondents Traveled to Doctors’ Appointments.
Note: One person did not report mode of transportation for colonoscopy appointment.
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Hoover et al. Page 10
Table 1
Demographics Education, and Employment Status of Patients Undergoing Colonoscopy.
Variables N %
Age (years)
 52–59 84 56.0
 60+ 66 44.0
Female 112 74.7
Race
 Black or African American 104 69.3
 Asian 28 18.7
 Other 18 12.0
Fluent in English 109 72.7
Highest grade of school or college finisheda
 Less than high school 41 27.3
 High school or GED 53 35.3
 More than high school 56 37.3
Employment status (patient)
 Working full-time 35 23.3
 Working part-time 22 14.7
 Not working (includes retired, staying at home to work, keeping house) 93 62.0
Current work status—position (patient)
 Services 32 56.1
 Other (e.g. transportation, production and maintenance) 25 43.9
Health insurance
 No insurance 126 84.0
 Medicaid/medical coupons/CHIP 14 9.3
 Other (Medicare, private coverage) 10 6.7
Relationship of person who accompanied you
 Spouse 26 17.3
 Friend 42 28.0
 Other family member 82 54.7
Employment status (caregiver)
 Working full-time 44 29.3
 Working part-time 22 14.7
 Not working (includes retired, staying at home to work, keeping house, don’t know) 84 56.0
Current work status—position (caregiver)
 Services 25 36.8
 Professional 12 17.6
 Other (e.g. transportation, production and maintenance) 31 45.7
aValues do not total 100% because of rounding.
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Table 3
Travel and Other Costs for Colonoscopy Office Visits.
N % of patients 
reporting activity
Mean cost per patient 
reporting activity
Mean cost per patient 
(across all patients)
Travel Cost
 Attend precolonoscopy office visit
 Cost to travel to doctor’s office by cara,b 103 68.7 $23.30 $4.17
 Cost to travel to doctor’s office by public 
transportationc
41 27.3 $5.00 $1.37
Subtotal $28.30 $5.54
Attend colonoscopy visit
 Cost to travel to doctor’s office by cara,b 134 89.3 $26.30 $6.28
 Cost to travel to doctor’s office by public 
transportationc
14 9.3 $5.00 $0.47
Subtotal $31.30 $6.75
Attend postcolonoscopy visit 13 8.7 $25.35 $0.81
  Costs of travel to attend postcolonoscopy visitb,d
Subtotal $25.35 $0.81
Total travel cost $13.10
 Cost of bowel preparation product 61 40.7 $10.71 $4.36
 Total $17.46
a
Includes cost of payment to be driven to doctor’s office, cost to park at doctor’s office and mileage costs.
bAssumed 10-mile distance to endoscopy center (round trip = 20 miles). Used 2013 IRS mileage for medical purpose of 23 cents. Excluded 
respondents who reported payment for transportation or took public transportation.
c
For transportation cost, the percentage of patients will not sum to 100% as some individuals walked and one person did not report mode of 
transportation for colonoscopy visit.
dOnly 20 respondents attended a postcolonoscopy visit. Due to small sample size, the following categories comprise the total but could not be 
reported separately: cost of payment to be driven to doctor’s office; cost to park at colonoscopy appointment; cost to travel to doctor’s office by 
bus, train, or taxi; mileage costs for postcolonoscopy visit.
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